Skip to main content

Vaccines Protect You & Your Kids From Measles: FDA

Medically reviewed by Carmen Pope, BPharm. Last updated on March 4, 2024.

By Ernie Mundell HealthDay Reporter

MONDAY, March 4, 2024 -- As new outbreaks of measles -- a once nearly eliminated illness in the United States -- continue to emerge, experts remind Americans that there's an easy way to stop infection: Get vaccinated.

"Measles spreads so easily that if one person has it, 90% of the people close to that person who are not vaccinated or otherwise immune will also become infected," the U.S. Food and Drug Administration warned in a statement released Friday.

Measles is spread through the air. It "starts with a fever, cough, runny nose, red eyes and sore throat," the FDA said. "Soon after, a rash of tiny, red spots breaks out." The rash begins at the head and spreads to the rest of the body.

FDA-approved vaccines can prevent infection, however, and are safe and highly effective.

Their track record is stellar: In 1963, before the launch of widespread measles immunization programs, up to 4 million Americans were sickened by the illness annually, the FDA said.

"Of those, 400 to 500 people died, 48,000 were hospitalized and 1,000 developed encephalitis [swelling of the brain] because of measles yearly," the agency noted.

Vaccination has turned that around, leading to a 99% decline in cases since immunization programs began.

Still, misinformation abounds and some parents may still balk at getting their kids the shot. Higher levels of unvaccinated people are a big factor behind outbreaks in communities.

So far, the FDA has approved two measles vaccines: MMR II and Priorix, for use in people ages 12 months and older. Kids ages 1 to 12 may also get the MMRV (measles, mumps and rubella and varicella) or ProQuad vaccine, which also shields kids from chickenpox.

Current recommendations from the U.S. Centers for Disease Control and Prevention advise that children get two doses of the MMR vaccine, starting with the first dose at age 12 through 15 months, with the second dose coming at ages 4 to 6. The same schedule holds true for kids who get the ProQuad shot.

As with any vaccine, side effects can occur. However, with all measles vaccines they are mild (fever and/or rash) and transient, the FDA said. The vaccine contains a small amount of weakened virus to prime your immune system should you become exposed.

"Before each vaccine’s approval, data from animal studies and from clinical trials in humans were evaluated by FDA scientists and doctors," the agency said.

Some rumors have suggested that the MMR vaccine is connected to autism; that is simply not true.

"Several organizations in addition to the CDC -- including the World Health Organization, the Institute of Medicine [now known as the National Academy of Medicine] and the American Academy of Pediatrics -- have conducted multiple studies," the FDA noted. "All those studies failed to show a causal relationship between vaccines and autism."

So, be sure to get your child vaccinated against measles. Doing so not only protects your child and your family, it can also protect folks who cannot be vaccinated. According to the FDA, these include infants under 6 months of age and people with compromised immune systems, such as cancer patients.

Sources

  • U.S. Food and Drug Administration, statement, March 1, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

There's a New Set of COVID Variants Called FLiRT: What You Need to Know

WEDNESDAY, May 8, 2024 -- The virus behind COVID has mutated again, this time producing variants nicknamed FLiRT, the U.S. Centers for Disease Control and Prevention (CDC) has...

Scientists Developing Vaccine Against Present and Future COVID Viruses

MONDAY, May 6, 2024 -- Scientists are busy working on a vaccine that might fight strains of the COVID virus SARS-CoV-2 that haven't even emerged yet. The effort from a British...

MRNA Vaccine Fights Deadly Brain Tumor in Small Trial

THURSDAY, May 2, 2024 -- An experimental cancer vaccine can quickly reprogram a person’s immune system to attack glioblastoma, the most aggressive and lethal form of brain...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.